Niagen Bioscience, Inc (NAGE) insider trading

Every open-market stock purchase and sale by Niagen Bioscience, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Ozan Pamir (CFO), $30.4K, 11 months ago.

Last 12 months: insiders bought $45.6K (1 buy) and sold $0 (0 sales). Last close $3.49 on Jul 9, 2026.

Recent NAGE insider trades

DateInsiderTradeValue
Jun 30, 2026Ozan Pamir (CFO)Bought (not open market)$11.5K
Jun 30, 2026Carlos Luis Lopez (VP)Bought (not open market)$6.3K
Jun 30, 2026Robert N Fried (CEO)Bought (not open market)$3K
Jun 24, 2026Hamed Shahbazi (Director)Bought (not open market)—
Jun 24, 2026Ann Cohen (Director)Bought (not open market)—
Jun 24, 2026Wang Yu Gary Ng (Director)Bought (not open market)—
Jun 24, 2026Wing Tak Wendy YU (Director)Bought (not open market)—
Jun 24, 2026Kristin Patrick (Director)Bought (not open market)—
Jun 24, 2026Steven D Rubin (Director)Bought (not open market)—
Jun 24, 2026Frank L Jaksch Jr (Director)Bought (not open market)—
Apr 24, 2026Robert N Fried (CEO)Bought (not open market)—
Feb 19, 2026Ozan Pamir (CFO)Bought (not open market)—
Feb 19, 2026Robert N Fried (CEO)Bought (not open market)—
Feb 19, 2026Carlos Luis Lopez (VP)Bought (not open market)—
Nov 14, 2025Ozan Pamir (CFO)Bought$30.4K
Nov 14, 2025Ozan Pamir (CFO)Bought$15.2K

Who's trading NAGE

Get free alerts when an insider at Niagen Bioscience, Inc files a new trade →